作者: N. Ghanem , M. Uhl , I. Brink , O. Schäfer , T. Kelly
DOI: 10.1016/J.EJRAD.2005.01.016
关键词: Bone marrow 、 Positron emission tomography 、 In patient 、 Nuclear medicine 、 Axial skeleton 、 Radiology 、 Scintigraphy 、 Metastasis 、 Medicine 、 Cancer 、 PET-CT
摘要: Abstract The initial localization of metastases in the bone patients with solid tumors has a relatively good prognosis comparison visceral metastasization. early detection marrow allows for rapid initiation therapy and subsequent reduction morbidity rate. Modern MRI is superior to 30-year-old skeletal scintigraphy respect sensitivity, specificity, as well extent osteal metastasis. provides sustantial, therapy-relevant additional information. MSCT plays an important role management cancer clinical routine gives excellent survey axial skeleton by demonstrating osteolytic osteoblastic metastases. Extensive comparative studies 18 F-FDG-PET F-fluoride-PET have not yet been carried out. Whole body very promising new staging method oncological diagnosis adoption FDG side PET-CT image fusion two one PET/CT examinations appears be slightly less sensitive whole Larger, prospective multicenter are necessary establish these new, methods